Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519056 | PMC |
| http://dx.doi.org/10.3346/jkms.2024.39.e323 | DOI Listing |
Publication Analysis
Top Keywords
letter editor
4
editor commentary
4
commentary "bevacizumab
4
"bevacizumab versus
4
versus bevacizumab
4
bevacizumab irinotecan
4
irinotecan patients
4
patients recurrent
4
recurrent glioblastoma"
4
letter
1
Similar Publications
Letter to the Editor Regarding "Caregivers' Perspective and Burden of the End-of-Life Phase of Patients with Glioblastoma: A Multicenter Retrospective Study".
World Neurosurg
January 2025
Department of Nursing, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China. Electronic address:
Letter to the Editor Regarding: "Phenotypic Characterisation of Obstructive Sleep Apnoea in Acute Coronary Syndrome" by Tong et al. Heart Lung Circ. 2024;33(12):1648-58.
Heart Lung Circ
January 2025
Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan. Electronic address:
Reply to Letter to the Editor Regarding: "Unilateral Chronic Thromboembolic Pulmonary Disease: Do Patients Benefit From Thromboendarterectomy?".
Heart Lung Circ
January 2025
Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address:
Letter to the Editor Regarding: "Unilateral Chronic Thromboembolic Pulmonary Disease: Do Patients Benefit From Thromboendarterectomy? Case Series From Three CTEPH Centres" By Rashidi et al. Heart Lung Circ. 2024;33(11):1574-81.
Heart Lung Circ
January 2025
University Centre for Research & Development Department of Pharmaceutical Sciences, Chandigarh University, Mohali, Punjab, India.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!